Sticker Shock: Is GW Pharmaceutical’s Epidiolex Really That Expensive?

Apart from $90 day cost, GW Pharma product is CBD FROM MARIJUANA, NOT HEMP, plus SESAME OIL, ALCOHOL, AND SUCRALOSE. Patients allergic to sesame were excluded from EPIDIOLEX studies, and SESAME ALLEGY IS NEITHER A WARNING NOR A PRECAUTION IN EPIDIOLEX LABELING. FDA plans to add sesame to list of most common food allergies. PATIENTS AND PARENTS BEWARE.

https://finance.yahoo.com/news/sticker-shock-gw-pharmaceuticals-epidiolex-153022990.html

 

Here’s What’s Next Now That The FDA Has Approved A Cannabis Drug For Seizures

The Drug Enforcement Administration is likely to reschedule the compound cannabidiol — but not cannabis itself

“The FDA has just approved this singular product through stringent testing and doses and specific concentrations. It’s gone through rigorous clinical reviews and FDA review, but the FDA is likely to still crack down on claims made with other (dietary supplement) products.”

https://www.theverge.com/2018/6/29/17518424/epidiolex-cbd-cannabis-fda-drugs-policy-law-health

Dr. Sanjay Gupta Spearheads American Pain Association’s Movement for Insurance Companies to Cover CBD

Simply put, CBD is marijuana (or cannabis) without THC, which is the psychoactive compound found in cannabis plants. CBD does not make patients high and is proving to have many health benefits,” Dr. Gupta said.

The OTHER Dr. Sanjay Gupta. Leading the American Pain Association, based in Philadelphia, in fighting for CBD insurance reimbursement.

https://todayspractitioner.com/cannabis/american-pain-association-spearheads-movement-for-insurance-companies-to-cover-cannabidiol-cbd/#.W-HNei2ZP-Y

Exclusive: New Report Predicts CBD Market Will Hit $22 Billion By 2022

Looking forward to relaxed hemp regulations, a new analysis estimates that the CBD market could explode — and outpace marijuana

“As consumers shift away from pharmaceutical companies and look for natural remedies, CBD seems to be the “drug” of the future. “It’s everything people believe to be good about marijuana, without the downside of getting stoned.”

https://www.rollingstone.com/culture/culture-news/new-study-cbd-market-22-billion-2022-722852/